The nationwide Finnish anticoagulation in atrial fibrillation (FinACAF): study rationale, design, and patient characteristics

Atrial fibrillation (AF) is a major cause of ischemic stroke and the number of AF patients is increasing. Thus, up-to-date multifaceted data about the characteristics of AF patients, their treatments, and outcomes are urgently needed. The Finnish anticoagulation in atrial fibrillation (FinACAF) stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehto, Mika, Halminen, Olli, Mustonen, Pirjo, Putaala, Jukka, Linna, Miika, Kinnunen, Janne, Kouki, Elis, Niiranen, Jussi, Hartikainen, Juha, Haukka, Jari, Airaksinen, Kari Eino Juhani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
New Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791884/
https://www.ncbi.nlm.nih.gov/pubmed/34985732
http://dx.doi.org/10.1007/s10654-021-00812-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791884/
https://www.ncbi.nlm.nih.gov/pubmed/34985732
http://dx.doi.org/10.1007/s10654-021-00812-x

Ejemplares similares